Income Statement
SILO PHARMA, INC.
SILO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.07 | 0.07 | 0.07 | - | - | 0.04 | 0.04 | - | - | - | - |
|
Cost of Revenue
|
0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.18 | 0.03 | - | - | - | - |
|
Gross Profit
|
0.03 | 0.07 | 0.07 | 0.07 | 0.07 | -0.14 | 0.01 | - | - | - | - |
|
Operating Expenses
|
4.31 | 4.77 | 3.92 | 3.69 | 2.81 | 2.44 | 0.94 | 0.59 | 0.01 | 0.04 | 0.05 |
|
Research & Development
|
2.16 | 2.37 | 0.85 | 1.29 | 0.69 | 0.03 | - | - | - | - | - |
|
Selling, General & Administrative
|
- | - | 0.39 | 0.23 | 0.16 | 0.12 | 0.09 | 0.08 | 0.01 | 0.04 | 0.05 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-4.28 | -4.71 | -3.86 | -3.63 | -2.74 | -2.57 | -0.93 | -0.59 | -0.01 | -0.04 | -0.05 |
|
Non-Operating Income
|
0.05 | 0.31 | 0.22 | -0.28 | 6.93 | -0.46 | -0.08 | -0.38 | - | - | - |
|
Interest Income
|
0.19 | 0.33 | 0.40 | 0.07 | 0.00 | - | - | - | 0.00 | - | - |
|
Interest Expense
|
- | - | 0.00 | 0.00 | 0.00 | 0.27 | 0.06 | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | 0.00 | - | 0.27 | - | - | - | - | - | - |
|
Income Before Tax
|
-4.23 | -4.39 | -3.63 | -3.91 | 4.18 | - | - | - | - | - | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.07 | 0.00 | 0.28 | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | 3.91 | 3.90 | - | - | - | - | - | - |
|
Net Income
|
-4.23 | -4.39 | -3.70 | -3.91 | 3.90 | -3.04 | -1.01 | -0.97 | - | -0.04 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-4.28 | -4.71 | -3.86 | -3.63 | -2.74 | -2.57 | -0.93 | -0.59 | -0.01 | -0.04 | -0.05 |
|
Earnings Per Share (Basic)
|
-0.50 | -1.19 | - | - | 0.04 | - | - | -0.02 | - | - | - |
|
Diluted EPS
|
-0.50 | -1.19 | - | - | 0.04 | - | - | -0.02 | - | - | - |
|
Weighted Average Shares
|
8.38 | 3.68 | 3.08 | 2.28 | 94.87 | - | - | - | 32.44 | - | - |
|
Diluted Weighted Avg Shares
|
8.38 | 3.68 | - | 2.28 | 95.92 | - | - | 49.10 | - | - | - |
|
Comprehensive Income
|
-4.22 | -4.38 | -3.71 | - | - | - | - | - | - | - | - |